Medifast (MED) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$1.65.
- Medifast's EPS (Weighted Average and Diluted) fell 245714.29% to -$1.65 in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.71, marking a year-over-year decrease of 105000.0%. This contributed to the annual value of -$1.7 for FY2025, which is 99473.68% down from last year.
- As of Q4 2025, Medifast's EPS (Weighted Average and Diluted) stood at -$1.65, which was down 245714.29% from -$0.21 recorded in Q3 2025.
- In the past 5 years, Medifast's EPS (Weighted Average and Diluted) registered a high of $3.96 during Q2 2021, and its lowest value of -$1.65 during Q4 2025.
- Over the past 5 years, Medifast's median EPS (Weighted Average and Diluted) value was $2.28 (recorded in 2022), while the average stood at $1.71.
- Examining YoY changes over the last 5 years, Medifast's EPS (Weighted Average and Diluted) showed a top increase of 12933.33% in 2025 and a maximum decrease of 245714.29% in 2025.
- Quarter analysis of 5 years shows Medifast's EPS (Weighted Average and Diluted) stood at $2.91 in 2021, then dropped by 16.49% to $2.43 in 2022, then tumbled by 77.37% to $0.55 in 2023, then plummeted by 87.27% to $0.07 in 2024, then tumbled by 2457.14% to -$1.65 in 2025.
- Its last three reported values are -$1.65 in Q4 2025, -$0.21 for Q3 2025, and $0.22 during Q2 2025.